Number of patients and relative frequency of recessively inherited coagulation disorders in Iran and Italy
Deficiency . | Iran, n (%) . | Italy, n (%) . |
|---|---|---|
| Fibrinogen | 80 (11) | 30 (8) |
| Prothrombin | 15 (2) | 18 (5) |
| V | 50 (7) | 35 (10) |
| VII | 300 (39) | 90 (25) |
| X | 75 (10) | 28 (8) |
| XI | 50 (7) | 80 (24) |
| XIII | 100 (13) | 40 (11) |
| V + VIII | 80 (11) | 32 (9) |
| Total | 750 | 353 |
Deficiency . | Iran, n (%) . | Italy, n (%) . |
|---|---|---|
| Fibrinogen | 80 (11) | 30 (8) |
| Prothrombin | 15 (2) | 18 (5) |
| V | 50 (7) | 35 (10) |
| VII | 300 (39) | 90 (25) |
| X | 75 (10) | 28 (8) |
| XI | 50 (7) | 80 (24) |
| XIII | 100 (13) | 40 (11) |
| V + VIII | 80 (11) | 32 (9) |
| Total | 750 | 353 |
The general population of Iran is 65 million; Italy, 55 million. Data on RICD are obtained from the most recent adjournments (2004) of the registries kept in Iran (courtesy of Dr. M. Lak, Iman Khomeini Hospital, Tehran) and in Italy (Associazione Italiana Centri Emofilia).